1. Opening Hook
While most companies blamed rain for poor sales, Mold-Tek managed to find salvation in plastic tubes. As the skies poured, pharma packaging rained profits. When the paint business dried up, bottles and caps came to the rescue—divine diversification, if you will.
As the Bhagavad Gita says, “In the heart of action, find stillness.” Mold-Tek found it—in pharma margins.
Stick around; it gets juicier than their yogurt tubs.
2. At a Glance
- Revenue up 9.65% – Rain tried; pharma defied.
- Volume up 7% – Buckets slowed, bottles boomed.
- EBITDA up 8.37% – Even spreadsheets smiled.
- Pharma sales up 45% QoQ – The new MVP in packaging.
- Paints up just 3% – Rains repainted their numbers.
- EBITDA/kg ₹39.4 vs ₹36.7 YoY – Pharma profits lightened the load.
- Capacity utilization 63% (down from 74%) – Machines took a monsoon nap.
3. Management’s Key Commentary
“Pharma packaging grew 45% QoQ; we’ll hit ₹35+ crore this year.”
(Translation: Finally, something to brag about beyond buckets.) 😏
“Paints suffered due to rains; people don’t paint during cyclones.”
(Translation: Nature canceled Diwali repainting season.)
“We see double-digit growth resuming in Q4.”
(Translation: Please don’t downgrade us yet, dear analysts.)
“Panipat plant started operations for food & FMCG.”
(Translation: North India, prepare for plastic dominance.)
“EBITDA/kg dipped due to lower utilization (63% vs 74%).”
(Translation: Empty machines eat profits.)
“F&F realization slipped below ₹300/kg due to competition.”
(Translation: New small
